Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related mortality
worldwide and its incidence continues to rise. While cirrhosis underlies most cases of HCC …

Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

Gallbladder cancer (GBC) is an uncommon disease in the majority of the world despite
being the most common and aggressive malignancy of the biliary tree. Early diagnosis is …

Purpose The role of postoperative therapy in extrahepatic cholangiocarcinoma (EHCC) or
gallbladder carcinoma (GBCA) is unknown. S0809 was designed to estimate 2-year survival …

Abstract Introduction The Asian Pacific Association for the Study of the Liver (APASL)
convened an international working party on the management of hepatocellular carcinoma …

Hepatic malignancies remain a global challenge. Hepatocellular carcinoma (HCC) accounts
for around 90% of patients with liver cancer and is the sixth most common neoplasm …

BACKGROUND Patients' perception of their prognosis has an impact on their decisions
about medical care. However, the relations between prognostic understanding and quality of …

Background The prognosis of patients with cholangiocarcinoma is unsatisfactory. Therefore,
evaluation of prognostic factors and establishment of new therapeutic strategies are needed …

Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

Phase II Trial of High-Dose Conformal Radiation Therapy With Concurrent Hepatic Artery
Floxuridine for Unresectable Intrahepatic Page 1 Phase II Trial of High-Dose Conformal …